{"success": true, "message": "Fetched question.", "data": {"showTimer": true, "showAttemptInsight": true, "playSounds": true, "dontShowCorrectAnswerImmediately": false, "_id": "6151e8632858d661103e3aa8", "type": "numerical", "level": null, "category": null, "approximateTimeRequired": null, "imageBaseUrl": null, "helperText": null, "source": "NTAS1", "classes": [], "exams": ["615d76b2c52ffa3c944600df"], "subjects": ["615d70bd9948bc1b21da2b1f"], "chapters": ["615d6fee2b295b085ab6ebb6"], "topics": [], "concepts": [], "microConcepts": [], "questionLabels": [{"title": "NTA Abhyas Paper", "value": "57", "isVisible": true}], "previousYearPapers": [], "question": {"text": "How many of the following compounds exhibit stereoisomerism?\r<table border=\"1px solid\">\r\t<thead>\r\t\t<tr>\r\t\t\t<th>i.</th>\r\t\t\t<th>2-Hydroxypropanoic acid</th>\r\t\t</tr>\r\t</thead>\r\t<tbody>\r\t\t<tr>\r\t\t\t<td>Ii.</td>\r\t\t\t<td>2-Methylbut-1-ene</td>\r\t\t</tr>\r\t\t<tr>\r\t\t\t<td>iii.</td>\r\t\t\t<td>Butane-2, 3-diol</td>\r\t\t</tr>\r\t\t<tr>\r\t\t\t<td>iv.</td>\r\t\t\t<td>3-Methylbutanoic acid</td>\r\t\t</tr>\r\t\t<tr>\r\t\t\t<td>v.</td>\r\t\t\t<td>3 -Methylbut- l-yne</td>\r\t\t</tr>\r\t\t<tr>\r\t\t\t<td>vi.</td>\r\t\t\t<td>2,3- Dichlorobutane</td>\r\t\t</tr>\r\t\t<tr>\r\t\t\t<td>vii.</td>\r\t\t\t<td>2-Bromo-3-methylpentane</td>\r\t\t</tr>\r\t\t<tr>\r\t\t\t<td>viii.</td>\r\t\t\t<td>2-Methylbutanoic acid</td>\r\t\t</tr>\r\t</tbody>\r</table>\r", "image": null}, "options": [], "correctValue": "5", "solution": {"text": "<img src=\"https://cdn-question-pool.getmarks.app/nta_abhyas/jee_main/images/151fcdbe-cec0-4724-9032-2291657c8d7e.png\" style=\"width:3.32083in;height:1.50972in\"> <br/><img src=\"https://cdn-question-pool.getmarks.app/nta_abhyas/jee_main/images/d6f28538-f7ec-472e-a108-8f7a9bc6407a.png\" style=\"width:3.57292in;height:1.39583in\"> <br/><img src=\"https://cdn-question-pool.getmarks.app/nta_abhyas/jee_main/images/e03fe831-d358-46c2-97fc-f934b81c532b.png\" style=\"width:2.29167in;height:0.73958in\">", "image": null}, "videoSolution": null, "numericalLowerLimit": null, "numericalUpperLimit": null, "cpyqbSubjects": ["615f0cf69476412f48314dac", "616057040283de43c87e3e16", "61bb58281213731910ea0b71", "6160579d0283de43c87e3e1f", "61964f94a5a526011886801e", "61c055f6e8ce0dc8a5c62d34", "61a8a2cce8ce0dc8a5c62d2e", "6160577e0283de43c87e3e1c", "616057210283de43c87e3e19", "629105adee9e3ae00d63352c", "62962075e7f8e9ac4daeafd8", "629f385f263330a77be9fa7e", "629f39e4ac11b26562e0625c", "61964ff3a5a5260118868022", "64d50c263df7f4a7f3017f70", "66b79b89d4b564dfab4f94d0", "678ea9a09cc79e5f592bdc12", "67fa602f4468eb1307ceb0ae", "6807d350647479b8e869647a"], "cpyqbChapters": ["616024b351f722cb35d69768", "616024b5635828cf45c2c86f", "616024b6d2493860e013037f", "616024b40048a39f6f22a9ec", "61964ca31c4aef0c16be05e7", "61bb821aa62a5cabef1ec237", "61c0899ad936cdbbae41cf5a", "61e7bd763d4a5821d8e1c282", "61964ca3ddb2ce8ed14e412e", "616024b5faac2d55bcb45537", "629f38ff4a0adb3149fa6f8d", "629109dc4f253f21a30897e2", "6296211811ee9cfa06f2361e", "629f3a85233d1ae59e12c20e", "64eb06c83118f713ecfef0c5", "66d5853da75f05ee8564f58b", "67921d721d5b5072da5e9b25", "67fdff53378e1624ea7b6a3a", "68091fe13a10446a207fdbe1"], "cpyqbExams": ["615f0e999476412f48314daf", "616059af0283de43c87e3e23"]}}